When it comes to the fight against infectious diseases, many would agree that prevention is key. It’s better to prevent an infection and protect the facility from liability and risk than perform reactive and costly remediation later. Preventing and controlling the transmission of the Clostridium difficile infections (CDIs) is a complex and evolving battle, but it’s a battle that can be won. C. diff bacteria has the potential to spread at an alarming rate, but healthcare facilities can reduce that risk by following strict infection control guidelines. This includes ensuring visitors adhere to strict visiting guidelines, regular hand washing, and consistent wiping of all equipment and the use of EPA registered products to kill C.diff on surfaces. The new CDC report finds that 94% of all C. difficile infections are connected to medical care settings, impacting patients not just in hospitals, but also in nursing homes, doctors’ offices and other outpatient settings. The report found that the pathogens are being moved from one facility to another as infected patients get moved, and necessary precautions to prevent the spread aren’t being taken. The CDC estimates about one-quarter of patients develop symptoms while in a hospital, the other 75% get sick in nursing homes, clinics or doctors’ offices. The right solution can interrupt transmission and prevent hospital-onset C. difficile infections. 2XL has developed CDiffend revolutionary tablets that are EPA registered to kill C. diff spores in 4 minutes with no bleach. With a near neutral pH level of 6.5, it provides a more stable solution that maintains efﬁcacy longer and is safer for patients and expensive equipment. CDiffend is less corrosive on surfaces or equipment and produces less odor than the bleach and peracetic acid-based products that have been used against C. diff spores.